JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis

Clinical trial NCT05443984 · COMPLETED

Trial details

NCT number: NCT05443984
Sponsor: Onconic Therapeutics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Erosive Esophagitis

Start date: 2022-01-17
Primary completion: 2023-01-05
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.